癌症（英文版）2016，Vol.35Issue(9)：468-475,8.DOI:10.1186/s40880-016-0120-4
Palliative primary tumor resection provides survival benefits for the patients with metastatic colorectal cancer and low circulating levels of dehydrogenase and carcinoembryonic antigen
Palliative primary tumor resection provides survival benefits for the patients with metastatic colorectal cancer and low circulating levels of dehydrogenase and carcinoembryonic antigen
WenZhuo He 1YuMing Rong 1Chang Jiang 1FangXin Liao 1ChenXi Yin 1GuiFang Guo 1HuiJuan Qiu 1Bei Zhang 1LiangPing Xia1
作者信息
- 1. State Key Laboratory of 0ncology in South China, Col aborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guang-zhou 510060, Guangdong, P. R. China
- 折叠
摘要
关键词
Metastatic colorectal cancer/Palliative primary tumor resection/Overall survival/Lactate dehydrogenase/Carcinoembryonic antigenKey words
Metastatic colorectal cancer/Palliative primary tumor resection/Overall survival/Lactate dehydrogenase/Carcinoembryonic antigen引用本文复制引用
WenZhuo He,YuMing Rong,Chang Jiang,FangXin Liao,ChenXi Yin,GuiFang Guo,HuiJuan Qiu,Bei Zhang,LiangPing Xia..Palliative primary tumor resection provides survival benefits for the patients with metastatic colorectal cancer and low circulating levels of dehydrogenase and carcinoembryonic antigen[J].癌症（英文版）,2016,35(9):468-475,8.
